Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrown Advisory Regulatory News (BASC)

Share Price Information for Brown Advisory (BASC)

Share Price is delayed by 15 minutes
Get Live Data
1,495.00    0.00 (0.00%)
Bid:
1,475.00
Ask:
1,495.00
Spread: 20.00 (1.356%)
Market Cap: £167.23m
BASC Live PriceLast checked at - London Stock Exchange

Intraday Brown Advisory Share Chart

Results analysis from Kepler Trust Intelligence

3 Oct 2025 10:47

RNS Number : 0247C
Brown Advisory US Smaller Cos. PLC
03 October 2025
 

Brown Advisory US Smaller Companies (BASC)

03/10/2025

Results analysis from Kepler Trust Intelligence

Brown Advisory US Smaller Companies' (BASC) results for the financial year ending 30/06/2025 show an NAV and share price total return of -3.7% and -1.0% respectively, compared to a total return of -0.7% for the benchmark Russell 2000. Sterling investors suffered from a weak dollar, and in USD terms the Russell 2000 returned 7.7% compared to the sterling return noted above.

BASC's underperformance mainly occurred in the first half of the year, with speculative and non-profitable stocks not held in the portfolio driving the benchmark's return. Over the long-term BASC's manager tends to be underweight in financials, preferring companies with less volatile and more sustainable earnings. This underweight cost some relative performance during the year as financials performed relatively well. BASC's overweight positions in industrials and information technology, and underweight in energy, all made positive contributions to performance, as did positive stock selection in the more out of favour healthcare sector.

Kepler View

Clearly recent performance has been disappointing but it's important to note that the main reason for this is that the stock market has chosen not to reward compounding growth quality companies, and instead favour high growth and more speculative businesses, rather than underperformance being explained by a series of companies with disappointing operational results. The BASC board has introduced a performance-related tender offer, which will give all investors the chance to realise their entire holding should performance lag the benchmark in the five years to the end of June 2028, and this, in our view, is a more measured way to address underperformance than to force change on an investment process that, over time, has delivered good performance.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFIFSAISLVIIE
Date   Source Headline
30th Dec 202510:28 amRNSNet Asset Value(s)
29th Dec 202511:49 amRNSNet Asset Value(s)
29th Dec 202510:00 amRNSNet Asset Value(s)
24th Dec 202510:06 amRNSNet Asset Value(s)
23rd Dec 202510:15 amRNSNet Asset Value(s)
22nd Dec 202510:20 amRNSDirectorate change
22nd Dec 202510:20 amRNSDirectorate change
22nd Dec 202510:13 amRNSNet Asset Value(s)
19th Dec 202510:31 amRNSNet Asset Value(s)
18th Dec 202510:23 amRNSNet Asset Value(s)
17th Dec 202510:03 amRNSNet Asset Value(s)
16th Dec 202510:09 amRNSNet Asset Value(s)
15th Dec 202510:03 amRNSNet Asset Value(s)
12th Dec 202510:31 amRNSNet Asset Value(s)
12th Dec 20259:57 amRNSPortfolio Update
11th Dec 20259:27 amRNSNet Asset Value(s)
10th Dec 20259:42 amRNSNet Asset Value(s)
9th Dec 202510:06 amRNSNet Asset Value(s)
8th Dec 202511:40 amRNSNet Asset Value(s)
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20259:54 amRNSNet Asset Value(s)
4th Dec 202511:18 amRNSNet Asset Value(s)
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20259:52 amRNSNet Asset Value(s)
2nd Dec 20252:36 pmRNSHolding(s) in Company
2nd Dec 202510:42 amRNSNet Asset Value(s)
2nd Dec 20257:00 amRNSHolding(s) in Company
1st Dec 20252:05 pmRNSTotal Voting Rights
1st Dec 202510:43 amRNSNet Asset Value(s)
28th Nov 202511:46 amRNSNet Asset Value(s)
27th Nov 202510:45 amRNSNet Asset Value(s)
26th Nov 202510:36 amRNSNet Asset Value(s)
25th Nov 202510:08 amRNSNet Asset Value(s)
24th Nov 202510:54 amRNSNet Asset Value(s)
21st Nov 202510:34 amRNSNet Asset Value(s)
20th Nov 20259:53 amRNSNet Asset Value(s)
19th Nov 202510:09 amRNSNet Asset Value(s)
18th Nov 202510:12 amRNSNet Asset Value(s)
17th Nov 202510:52 amRNSNet Asset Value(s)
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 202510:01 amRNSNet Asset Value(s)
14th Nov 20257:00 amRNSPortfolio Update
13th Nov 202510:28 amRNSNet Asset Value(s)
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 202511:12 amRNSNet Asset Value(s)
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20259:45 amRNSNet Asset Value(s)
10th Nov 20254:57 pmRNSResult of AGM
10th Nov 202510:27 amRNSNet Asset Value(s)
7th Nov 202510:07 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.